Kim Michelet

Kim Michelet is a highly-effective and results-oriented market-access biotech leader with 16 years of experience in key oncology market access roles.

Known for account management leadership, policy and reimbursement, market-access marketing, oncology sales training, and oncology sales leadership.

Demonstrated success in building and leading high-performing teams through collaborative leadership resulting in teamwork, trust, innovation, accountability, and execution of objectives.

Skilled in developing medium to long term market access strategies and innovating in developing IDN and payer strategies.

Experienced in successful payer/IDN pre-post launch strategies of over 14 oncology products in the last 10 years including IV, oral, Car-t therapy, and diagnostics.

Has outstanding consultative capabilities in forecasting marketplace landscape to upper management.

Specializes in reimbursement and policy innovation in biotechnology, pharmaceuticals, Part B, Part D, diagnostics, Cart-t therapy, gene therapy, immunotherapy, oncology, and hematology.

Proficient in developing coding, coverage, and payment strategies, and has developed multiple payer and reimbursement strategies.

Successfully partner with senior leadership across business units for cross-functional leadership and has received multiple awards for cross-functional teamwork.

Known for strategic planning and business development acumen by developing strategies from ground-up, conducting market research, data analyses, and executing strategic customer approaches.

Consistently recognized as an innovator, top-performer, and multiple award winner for results and demonstrating company values.

Educational background includes a Masters degree in leadership/management, public speaking training, and a certificate in health economics research.

Published work includes being a Co-Author of Payer Engagement-Metastatic Prostate Cancer and presenting a Poster at ISPOR.

Professional experience includes roles as Director of Market Access at Seagen, Associate Director Managed Markets at Seagen, Senior Director National Market Access at Verastem Oncology, Senior Director at Novartis Oncology Market Access, Payer Access & Reimbursement Manager at Sanofi-Aventis Oncology, Oncology Reimbursement Manager at Sanofi-Aventis Oncology, and Managed Markets-Regional Account Manager at Sanofi-Aventis.